Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 19, 2019 - Issue 10: Biosimilars
Submit an article Journal homepage
333
Views
3
CrossRef citations to date
0
Altmetric
Review

Biosimilars for breast cancer

Bruna Migliavacca ZucchettiDivision of Early Drug Development for Innovative Therapy, European Institute of Oncology IRCCS, Milan, Italy;Hospital Sirio-Libanes, Sao Paulo, BrazilView further author information
,
Eleonora NicolòDivision of Early Drug Development for Innovative Therapy, European Institute of Oncology IRCCS, Milan, Italy;Department of Oncology and Hematology, University of Milano, Milan, ItalyView further author information
&
Giuseppe CuriglianoDivision of Early Drug Development for Innovative Therapy, European Institute of Oncology IRCCS, Milan, Italy;Department of Oncology and Hematology, University of Milano, Milan, ItalyCorrespondence[email protected]
View further author information
Pages 1015-1021 | Received 21 Feb 2019, Accepted 27 Jun 2019, Published online: 10 Jul 2019

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Wojciech Jurczak, Monika Długosz Danecka & Christian Buske. (2019) Rituximab biosimilars for lymphoma in Europe. Expert Opinion on Biological Therapy 19:10, pages 1045-1056.
Read now

Articles from other publishers (2)

Elizabeth Lerner Papautsky, Martha Carlson, Sheila M. Johnson, Hannah Montague, Deanna J. Attai & Maryam B. Lustberg. (2022) Characterizing experiences of non-medical switching to trastuzumab biosimilars using data from internet-based surveys with US-based oncologists and breast cancer patients. Breast Cancer Research and Treatment 194:1, pages 25-33.
Crossref
Çağla KÜÇÜK, Özlem ATEŞ DURU, Esra MUTLU & Hande KAZAK SARİLMİSER. (2021) Biyobenzer İlaçlar. Beykent Üniversitesi Fen ve Mühendislik Bilimleri Dergisi 13:2, pages 34-42.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.